Ping Cui, MD
Geriatric Psychiatry · Haverhill, MANPI 1558363564
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Shire North American Group Inc at 26.6% of the total. Reporting peaked in 2019 at $453 and has fallen 77.9% since, to $100 in 2025.
Across 46 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$177
- Lundbeck LLC$77
- Otsuka America Pharmaceutical, Inc.$72
- Johnson & Johnson$71
- Sunovion Pharmaceuticals Inc.$64
- Eisai Inc.$50
- plus $155 from 4 others
What the payments were for
- Food & beverage$667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 19 | $177 |
| Lundbeck LLC | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $72 |
| Johnson & Johnson | 4 | $71 |
| Sunovion Pharmaceuticals Inc. | 4 | $64 |
| Eisai Inc. | 1 | $50 |
| AbbVie | 4 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
How this compares
$667 in reported general payments places this provider in the 55th percentile of 23 geriatric psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 35 | $7,452 |
| Lurasidone Hcl | 40 | $6,486 |
| Memantine Hcl ErMemantine Hcl | 17 | $2,773 |
| Quetiapine Fumarate | 41 | $2,476 |
| Bupropion Hcl SrBupropion Hcl | 92 | $2,082 |
| Ziprasidone Hcl | 33 | $1,520 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 127 | $1,380 |
| Duloxetine Hcl | 52 | $1,316 |
| Oxcarbazepine | 21 | $1,314 |
| Mirtazapine | 48 | $1,018 |
| Trazodone Hcl | 81 | $976 |
| Memantine Hcl | 12 | $938 |
| Gabapentin | 90 | $908 |
| Clonazepam | 119 | $888 |
| Topiramate | 27 | $785 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Haverhill
- Brent ForesterWestford$34K
- Feyza MaroufBoston$10K
- Bruce GoldbergDanvers$6K
- Olga GaftanyukShrewsbury$2K
- Hon HoLynn$2K
- Patricia WalshLynn$2K
- Max BaranovskyBrighton$1K
- James EllisonOsterville$1K
- Robert PortneyAndover$887
- Alfredo ChanHanover$709
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.